Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008;53(11-12):1012-1015.
doi: 10.1007/s10038-008-0336-5. Epub 2008 Oct 16.

LRRK2 P755L variant in sporadic Parkinson's disease

Affiliations
Comparative Study

LRRK2 P755L variant in sporadic Parkinson's disease

Hiroyuki Tomiyama et al. J Hum Genet. 2008.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder of unknown etiology with probable involvement of genetic-environmental factors. The majority of PD cases (approximately 90-95%) are sporadic, while familial cases account for approximately 5-10% of PD. In a recent report, a heterozygous LRRK2 P755L mutation within LRRK2 exon 19 was found in 2% of Chinese sporadic PD patients and in 0% of normal controls or Caucasians, suggesting that the mutation is disease-associated with ethnic specificity. To further evaluate the role of LRRK2 P755L variant in sporadic PD, we performed direct sequencing of LRRK2 exon 19 in 501 Japanese sporadic PD patients (male 249, female 252, aged 28-92 years, mean 65.0 years) and 583 controls of the Japanese general population as an extended association study. In this group, we found six patients (6/501 = 1.2%) and eight controls of the general population (8/583 = 1.6%) with a heterozygous P755L variant (P = 0.80, chi(2) = 0.064). No other variants were found in exon 19. Together with previous reports, our extended case-controlled study of large sample size suggests that LRRK2 P755L is a non-disease-associated polymorphism in PD patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 2005 Jan 29-Feb 4;365(9457):415-6 - PubMed
    1. Neuron. 2004 Nov 18;44(4):601-7 - PubMed
    1. Neuroreport. 2007 Feb 12;18(3):273-5 - PubMed
    1. Hum Genet. 2007 Feb;120(6):857-63 - PubMed
    1. Ann Neurol. 2002 Mar;51(3):296-301 - PubMed

Publication types

Substances

LinkOut - more resources